Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial
文献类型：期刊论文
| 作者 | Yang, Li1; Cao, Qingjiu1; Shuai, Lan1; Li, Haimei1; Chan, Raymond C. K.2 ; Wang, Yufeng1
|
| 刊名 | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
 |
| 出版日期 | 2012-02-01 |
| 卷号 | 15期号:1页码:15-26 |
| 关键词 | Attention deficit hyperactivity disorder atomoxetine executive function osmotic release oral system-methylphenidate (OROS-MPH) |
| ISSN号 | 1461-1457 |
| 产权排序 | 2 |
| 通讯作者 | Wang, YF (reprint author), 51 Huayuan Bei Rd, Beijing 100191, Peoples R China. |
| 英文摘要 | This study aimed to compare the effects of osmotic release oral system-methylphenidate (OROS-MPH) and atomoxetine (ATX) on executive function in children and adolescents with attention deficit hyperactivity disorder (ADHD) by a randomized controlled trial. Subjects who met DSM-IV ADHD criteria were randomized to receive either OROS-MPH or ATX treatment. The doses were titrated to achieve optimal response and then maintained for 4-6 wk. A battery of executive function tests and the Behavior Rating Inventory of Executive Function (BRIEF) were administered to subjects who completed the dose titration (OROS-MPH, n = 85; ATX, n = 57) at the pre- and post-treatment periods. Forty-six children without ADHD were recruited as controls. Both OROS-MPH and ATX significantly improved scores in the Rey Complex Figure Test (RCFT), digit span, and Stroop color-word task. The scores in RCFT and the reverse digit span were not significantly different from the control group at post-treatment assessment (OROS-MPH = ATX = control, p > 0.05), whereas the word interference time of the Stroop test was still more than that of the control group (OROS-MPH = ATX > control, p > 0.05). OROS-MPH also significantly improved the total correct response in the verbal fluency test to normal level, and the shifting time in the trail-making test to subnormal level. The current findings suggest both OROS-MPH and ATX improved executive function generally in children and adolescents with ADHD, and could return working memory back to normative performance level. |
| 学科主题 | Developmental psychology |
| 收录类别 | SCI |
| 项目简介 | This research was funded by National Natural Science Foundation of China (30800302), Chinese Ministry of Health grants (200802073), Ministry of Science and Technology grants (2007BAI17B03) and the Xian-Janssen Pharmaceutical Ltd (CON-I-07-CN-029-B). We acknowledge the Clinical Epidemiology Research Centre of Peking University Third Hospital, for assistance in generating the randomization envelope. We also thank postgraduate fellows Qiaoxin Du, Ning Ji, Lu Liu, Li An, Yi Su, who helped in the data collection.The corresponding author was supported by a research grant from Xian-Janssen. The first author received consulting fees from Eli Lilly and lecture fees from Xian-Janssen Pharmaceutical Ltd. |
| 语种 | 英语 |
| WOS记录号 | WOS:000299498600002 |
| 源URL | [http://ir.psych.ac.cn/handle/311026/11447]  |
| 专题 | 心理研究所_脑与认知科学国家重点实验室 |
| 作者单位 | 1.Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China 2.Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Key Lab Mental Hlth, Beijing 100101, Peoples R China |
| 推荐引用方式 GB/T 7714 | Yang, Li,Cao, Qingjiu,Shuai, Lan,et al. Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY,2012,15(1):15-26. |
| APA | Yang, Li,Cao, Qingjiu,Shuai, Lan,Li, Haimei,Chan, Raymond C. K.,&Wang, Yufeng.(2012).Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial.INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY,15(1),15-26. |
| MLA | Yang, Li,et al."Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial".INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 15.1(2012):15-26. |
入库方式： OAI收割
来源：心理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。